Cholecystokinin hyperresponsiveness in functional dyspepsia

World Journal of Gastroenterology

Volumn 12, Issue 17, 2006, Pages 2688-2693

  Chua, Andrew Seng Boon ^a   Keeling, P W N ^b  

^a Ipoh Gastro Centre   (Malaysia)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cholecystokinin hyperresponsiveness; Functional dyspepsia; Sensorimotor dysfunction; Stress

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ATROPINE; BUSPIRONE; CHOLECYSTOKININ; DESIPRAMINE; DEXLOXIGLUMIDE; LOXIGLUMIDE; NORADRENALIN; PLACEBO; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR; SUMATRIPTAN;

ARTICLE; BLOATING; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DYSPEPSIA; EPIGASTRIC PAIN; FOOD INTAKE; HEARTBURN; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; MENTAL STRESS; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROVOCATION TEST; SATIETY; STOMACH DISTENSION; STOMACH EMPTYING; STOMACH MOTILITY; SYMPTOMATOLOGY; VOMITING;

EID: 33744465293     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i17.2688     Document Type: Article

References (67)

1. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II, The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment; A Multinational Consensus 2nd ed. McLean VA, Degnon Associates; 2000
2. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-181
3. Read NW. Food and hypersensitivity in functional dyspepsia. Gut 2002; 51 Suppl 1: i5O-i53
4. Camilleri M. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc 1996; 71: 614-622
5. Kissileff HR, Carretta JC, Geliebter A, Pi-Sunyer FX. Cholecystokinin and stomach distension combine to reduce food intake in humans, Am J Physiol Regul Integr Comp Physiol 2003; 285: R992-R998
6. Linden A, Uvnas-Moberg K Forsberg G, Bednar I, Sodersten P. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide. J Endocrinol 1989; 121: 59-65
7. Baile CA, McLaughlin CL, Della-Fera MA. Role of cholecystokinin and opioid peptides in control of food intake. Physiol Rev 1986; 66: 172-234
8. Raybould HE, Tache Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol 1988; 255: G242-G246
9. Liddle RA, Morita ET, Conrad CK, Williams JA. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1986; 77; 992-996
10. Lieverse RJ, Jansen JB, Masclee AA, Lamers CB. Role of cholecystokinin in the regulation of satiation and satiety in humans. Ann N Y Acad Sci 1994; 713: 268-272
11. Lal S, McLaughlin J, Barlow J, D'Amato M, Giacovelli G, Varro A, Dockray GJ, Thompson DG. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am J Physiol Gastrointest Liver Physiol 2004; 287: G72-G79
12. Bradwejn J, Koszycki D. The cholecystokinin hypothesis of anxiety and panic disorder. Ann N Y Acad Sci 1994; 713: 273-282
13. Stanghellini V, Tosetti C, Paternico A, De Giorgio R, Barbara G, Salvioli B, Corinaldesi R. Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999; 94: 2080-2085
14. Sarnelli G, Caenepeel P, Geypens B, Janssens J, Tack J. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783-788
15. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001; 96: 1422-1428
16. Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996; 41: 689-696
17. Berstad A, Hauksen T, Gilja OH, Hveem K, Undeland KA, Wilhelmsen I, Haug TT. Gastric accommodation in functional dyspepsia. Scand J Gastroenterol 1997; 32: 193-197
18. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-1352
19. Boeckxstaens GE, Hirsch DP, Kuiken SD, Heisterkamp SH, Tytgat GN. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002; 97: 40-48
20. Azpiroz F. Hypersensitivity in functional gastrointestinal disorders. Gut 2002; 51 Suppl 1: i25-i28
21. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-535
22. Salet GA, Samsom M, Roelofs JM, van Berge Henegouwen GP, Smout AJ, Akkermans LM. Responses to gastric distension in functional dyspepsia. Gut 1998; 42: 823-829
23. Fried M, Erlacher U, Schwizer W, Lochner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991; 101: 503-511
24. Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Gut 1994; 35: 501-505
25. Miaskiewicz SL, Stricker EM, Verbalis JG. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans. J Clin Endocrinol Metab 1989; 68: 837-843
26. Von Korff RV. Properties of mitochondrial monoamine oxidase isolated from rabbit brain and liver. Biokhimiia 1977; 42: 396-402
27. Mesquita MA, Thompson DG, Troncon LE, D'Amato M, Rovati LC, Barlow J. Effect of cholecystokinin-A receptor blockade on lipid-induced gastric relaxation in humans. Am J Physiol 1997; 273: G118-G123
28. Bradette M, Pare P, Douville P, Morin A. Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 1991; 36: 52-58
29. Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci 1991; 36: 1249-1254
30. Katchinsky M. The role of CCK and CCK antagonists in humans esophageal and gastroduodenal motility. In : G Adler and C Beglinger. CCK antagonists in gastroenterology. Springer-Verlag Berlin, 1991: 173-182
31. McCann MJ, Hermann GE, Rogers RC. Nucleus raphe obscurus (nRO) influences vagal control of gastric motility in rats. Brain Res 1989; 486: 181-184
32. Raybould HE, Gayton RJ, Dockray GJ. Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat. J Neurosci 1988; 8: 3018-3024
33. Raybould HE, Gayton RJ, Dockray GJ. CNS effects of circulating CCK8: involvement of brainstem neurones responding to gastric distension. Brain Res 1985; 342:187-190
34. Raybould HE, Roberts ME, Dockray GJ. Reflex decreases in intragastric pressure in response to cholecystokinin in rats. Am J Physiol 1987; 253: G165-G170
35. VLW Go. The physiology of cholecystokinin. In: Gut hormones. Edinburgh: Churchill Livingstone, 1978: 203
36. Smith GP, Gibbs J. Satiating effect of cholecystokinin. Ann N Y Acad Sci 1994; 713: 236-241
37. Robinson PH, McHugh PR, Moran TH, Stephenson JD. Gastric control of food intake. J Psychosom Res 1988; 32: 593-606
38. Moran TH, McHugh PR. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol 1982; 242: R491-R497
39. Feinle C, Grundy D, Read NW. Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension. Am J Physiol 1997; 273: G721-G726
40. Barbera R, Feinle C, Read NW. Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 1995; 7: 1051-1057
41. Barbera R, Feinle C, Read NW. Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 1995; 40: 1636-1641
42. Feinle C, Meier O, Otto B, D'Amato M, Fried M. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001; 48: 347-355
43. Fried M, Feinle C. The role of fat and cholecystokinin in functional dyspepsia. Gut 2002; 51 Suppl 1: i54-i57
44. Hopman WP, Jansen JB, Lamers CB. Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man. Scand J Gastroenterol 1985, 20: 843-847
45. Schwartz GJ, McHugh PR, Moran TH. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol 1993; 265: R872-R876
46. Chua AS, Dinan TG, Rovati LC, Keeling PW. Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia. Ann N Y Acad Sci 1994; 713: 298-299
47. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology 1995; 109: 1772-1780
48. Monnikes H, Tebbe JJ, Hildebrandt M, Arck P, Osmanoglou E, Rose M, Klapp B, Wiedenmann B, Heymann-Monnikes I. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 2001; 19:201-211
49. Dinan TG, Mahmud N, Rathore O, Thakore J, Scott LV, Carr E, Naesdal J, O'Morain CA, Keeling PW. A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia-are central serotoninergic responses enhanced? Aliment Pharmacol Ther 2001; 15: 1613-1618
50. Chua A, Keating J, Hamilton D, Keeling PW, Dinan TG. Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. BMJ 1992; 305: 280-282
51. Chua A, Ah-Kion S, Hamilton D, Dinan TG, Keeling PW. Abnormal forebrain noradrenergic alpha-2 receptors functioning in patients with delayed gastric emptying. Ir J Med Sci l990;159:223
52. Chua A, Dinan TG, Weir DG, Keeling PW. Abnormal cholecystokinin response in non-ulcer dyspeptic patients is associated with an abnormal central serotonergic and noradrenergic function. Hellenic J Gastroenterol 1992; 5: A189
53. Mayer EA, Craske M, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry 2001; 62 Suppl 8: 28-36; discussion 37
54. Naliboff BD, Mayer M, Fass R, Fitzgerald LZ, Chang L, Bolus R, Mayer EA. The effect of life stress on symptoms of heartburn. Psychosom Med 2004; 66:426-434
55. Gomez J, Dally P. Psychologically mediated abdominal pain in surgical and medical outpatients clinics. Br Med J 1977; 1: 1451-1453
56. Magni G, di Mario F, Bernasconi G, Mastropaolo G. DSM-III diagnoses associated with dyspepsia of unknown cause. Am J Psychiatry 1987; 144: 1222-1223
57. Hill DR, Woodruff GN. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Res 1990; 526: 276-283
58. Woodruff GN, Hill DR, Boden P, Pinnock R, Singh L, Hughes J. Functional role of brain CCK receptors. Neuropeptides 1991; 19 Suppl: 45-56
59. Saito A, Sankaran H, Goldfine ID, Williams JA. Cholecystokinin receptors in the brain: characterization and distribution. Science 1980; 208: 1155-1156
60. Lindefors N, Linden A, Brene S, Sedvall G, Persson H. CCK peptides and mRNA in the human brain. Prog Neurobiol 1993; 40: 671-690
61. Stallone D, Nicolaidis S, Gibbs J. Cholecystokinin-induced anorexia depends on serotoninergic function. Am J Physiol 1989; 256: R1138-R1141
62. Beresford IJ, Hall MD, Clark CR, Hill RG, Hughes J. Cholecystokinin modulation of [3H] noradrenaline release from superfused hypothalamic slices. Neurosci Lett 1988; 88: 227-232
63. Crawley JN. Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 1991; 12:232-236
64. Abelson JL, Nesse RM. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Biol Psychiatry 1994; 36: 73-83
65. Abelson JL, Nesse RM, Vinik AI, Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry 1994; 36: 84-96
66. Abelson JL, Liberzon I. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. Neuropsychopharmacology 1999; 21: 485-494
67. Chua AS, Bekkering M, Rovati LC, Keeling PW. Clinical efficacy and prokinetic effect of the CCK-A antagonist loxiglumide in nonulcer dyspepsia. Ann N Y Acad Sci 1994; 713: 451-453